Niki BioSolutions NIKI
NASDAQ NIKI
$4.60 -0.26 (-5.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Asset Writedowns and Impairment (2024 - 2025)

Updated

Niki BioSolutions' Asset Writedowns and Impairment came in at -$12,824 for Q1 2025, compared with -$8,989 a year earlier.

Analysis

Niki BioSolutions (NIKI) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

For FY2024, Niki BioSolutions' Asset Writedowns and Impairment was $1.7 million, up 126.5% from FY2023.

  • Asset Writedowns and Impairment carries a four-year compound annual growth rate of 70.7% (FY2020 to FY2024).
  • Going back by year, Asset Writedowns and Impairment was $750,381 in FY2023 (+44.1%), $520,821 in FY2022 and $200,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Niki BioSolutions 2.51 Mn 2.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 -12,824.00
Aug 31, 2024 -8,989.00
API Access

Niki BioSolutions Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=NIKI&period=max&api_key=YOUR_API_KEY